UBS, Trims

UBS Trims Legacy Risk on Three Fronts While Bern Debates a Levy Only It Would Pay

Published on 10/15/2026 at 23:40 | Editorial boerse-global.de
UBS offloads £1.7bn UK pension obligations to Legal & General and agrees to transfer Credit Suisse fund administration units to Northern Trust.
UBS Group AG CH0244767585 als Pop-Art-Comic mit stilisiertem Tresor und goldenem Schlüssel im farbstarken Halftone-Raster Illustration mit AI erstellt.

UBS has spent the past week quietly shrinking its footprint in businesses it no longer wants, even as the political temperature around its Swiss capital requirements keeps climbing. The bank's UK pension scheme struck a £1.7 billion buy-in with Legal & General Assurance Society on Tuesday, a deal covering the retirement obligations of more than 7,000 members. As part of the arrangement, an existing longevity-risk hedge with Zurich was transferred across to Legal & General.

Transactions of this kind shift financial obligations gradually onto specialist insurers, giving pension funds a firmer grip on future costs. For the Swiss group, the move chips away at actuarial uncertainty inside its British retirement operation.

Portfolio Shifts and a Fund-Servicing Exit

Elsewhere on the balance sheet, UBS adjusted its securities holdings. In the Azelis Group NV, the bank reported crossing the 3.00% notification threshold after acquiring voting-rights shares and financial instruments. Following completion of those transactions, it held 0.38% of voting shares as of October 6, with the far larger slice — 2.63% — sitting in equivalent financial instruments. Such reshuffling reflects the routine management of the bank's own positions and derivative exposures.

The same day brought a more structural move: UBS agreed to hand the Credit Suisse fund administration businesses in Switzerland and Luxembourg to Northern Trust. The transfer, subject to regulatory approvals, is slated to close in the second quarter of 2027 and marks a full retreat from that line of work.

Should investors sell immediately? Or is it worth buying UBS?

Contingency Thinking Meets a Swiss-Only Fee

All of this lands in the middle of a regulatory fight at home. The Swiss Council of States' economic affairs committee, WAK-S, has backed an upfront fee for the state's Public Liquidity Backstop. In the committee's assessment, only UBS — among institutions with substantial foreign operations — would be affected by the new rule. The panel also proposed folding bail-in debt and selected long-term funding sources into the assessment base.

According to Reuters, the bank is simultaneously working through internal scenarios should Switzerland tighten its equity capital rules. Options under review reportedly include relocating its headquarters abroad, a merger, or the purchase of a smaller US bank — or an outright takeover. Reuters stressed that no active negotiations are underway. The bank declined to comment, and the agency said it could not independently verify the report, which it traced to the Wall Street Journal.

Investor pressure has added to the mix. In early October, shareholder Artisan Partners wrote to the board urging it to leave Switzerland. Bloomberg reports that the firm holds more than 60 million UBS shares on behalf of clients, equivalent to roughly 1.8%.

Analysts Stay Constructive as the Stock Sits Below Its High

Despite the political noise, the shares have held their ground. The stock trades at EUR 42.48, up 0.5%, keeping it above its 200-day moving average of EUR 40.85. It remains about 12% below its 52-week high of EUR 48.19.

Analysts have largely taken the recent developments in stride. On October 6, J.P. Morgan reaffirmed its "Overweight" rating with a CHF 50 price target. Deutsche Bank Research had issued a buy recommendation roughly a week earlier, setting its target at CHF 47.

Attention now turns to the earnings calendar. On October 28, 2026, the Swiss banking group will publish its interim report for the third quarter ended September 30, 2026.

Ad

UBS Stock: New Analysis - 15 October

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

Disclaimer...
en | CH0244767585 | UBS | boerse | 70333902 |